FDA Offers Flexible Enforcement of Product Name Placement

Washington Drug Letter
A drug’s active ingredient name does not need to appear every time its brand name is repeated in an advertisement, the FDA says, clarifying the most common advertising issue that drugmakers question the agency about.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00